Andere talen Immunovant, Inc.

Aandelen

IMVT

US45258J1025

Geschatte realtime Cboe BZX Andere beurzen 16:40:03 28-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
26,03 ^USD	+0,12%		-4,50%	-38,07%

03/06	IMMUNOVANT, INC. : Oppenheimer bevestigt koopadvies	ZM
30/05	Sectorupdate: Gezondheidszorgaandelen gemengd voor de beurs op donderdag	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Sector Update: Health Care Stocks Mixed Pre-Bell Thursday	30/05
Immunovant Q4 Loss Widens -- Shares Fall After-Hours	29/05
Immunovant Provides Corporate Updates and Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024	29/05
Immunovant, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024	29/05
Immunovant, Inc. Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	29/05
Immunovant Insider Sold Shares Worth $479,233, According to a Recent SEC Filing	24/05
Immunovant Insider Sold Shares Worth $990,269, According to a Recent SEC Filing	20/04
Immunovant Insider Sold Shares Worth $293,923, According to a Recent SEC Filing	20/04
Immunovant Awarded U.S. Patent for IMVT-1402	12/03
Immunovant Insider Sold Shares Worth $486,362, According to a Recent SEC Filing	23/02
Immunovant Posts Narrower Fiscal Q3 Loss	12/02
Immunovant, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	12/02
Immunovant Reports Financial Results and Provides Corporate Updates for the Quarter Ended December 31, 2023	12/02
North American Morning Briefing : Stock Futures -2-	09/02
North American Morning Briefing : Jobs Report Tops -2-	02/02
Immunovant Insider Sold Shares Worth $383,012, According to a Recent SEC Filing	29/01
Immunovant to Present at the 42nd Annual J.P. Morgan Healthcare Conference	03/01
Sector Update: Health Care Stocks Edge Higher Premarket Thursday	21/12
Immunovant Gets Positive Data From Graves' Disease Treatment Trial	20/12
Immunovant's Batoclimab for Graves' Disease Produces Meaningful Response Rates in Study; Shares Jump After Hours	20/12

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Immunovant, Inc.

Aandelen

IMVT

US45258J1025

Andere talen

Filters